Protein Crystallography: Automating a Temperamental Science

How does the lab manager best implement automated technologies to optimize experimental workflow for improved cost-and time-efficiency?

Written byLab Manager
| 9 min read
Register for free to listen to this article
Listen with Speechify
0:00
9:00

With the evolution of proteomics and the completion of the human genome project, protein crystallography has developed into a key area of pharmaceutical research. The sensitivity of this technique for identifying three dimensional protein structures means it has proved invaluable for the process of rational drug design. As a result, the protein crystallography laboratory has been subject to growing pressures. As technological advances have allowed screening laboratories to increase throughput and maximize hit-to-lead success, it was rapidly realized that in order to prevent bottlenecks in the discovery pipeline, the protein crystallography lab must also keep pace. This has not been easy as individual proteins or protein families have specific requirements and crystallography methodologies and manual techniques are traditionally used for crystallization set-up and optimization. Nevertheless, in recent years technology providers have developed innovative technologies for the protein crystallography lab without compromising experimental flexibility and most of all, data quality. But what has this meant for the lab manager? What are the financial implications of such investment? How has the move to automated technologies been accepted by the scientists in what was once a very “hands-on” discipline?

AN INTEGRATED RESEARCH SET-UP

The role of many protein crystallography teams within pharma is predominantly to provide support to lead discovery programs. As such, they are very closely linked with many research areas and departments across the whole enterprise. The crystallography team is primarily involved with the crystallization and characterization of proteins. This includes activities such as screening, optimization of hits, crystal production, diffraction data collection, and structure determination. However, interactions with other teams, both upstream and downstream of the protein crystallography group, are essential for the successful contribution to any drug discovery program. These teams may include molecular biologists, protein engineers, and biophysicists to identify the targets and supply the proteins to be crystallized, in addition to computational and medicinal chemists, cell biologists, and biochemists, for downstream validation and further discovery efforts. This set-up often means that the crystallography team must not only be dynamic and flexible to meet changing demands but also have the combined expertise and crystallography know-how to deliver within a set time frame. Such enterprise-wide activities require seamless or near seamless interactions across departments and multiple sites worldwide, with regular meetings to address issues and reevaluate objectives.

ESTABLISHING PRIORITIES

Providing this level of support requires the protein crystallography lab manager to understand the needs of the various therapeutic areas and prioritize targets efficiently. Obviously, one of the associated pressures is effective time management. The timely delivery of crystal structures can greatly assist the decision making process as to what leads to follow and how. Additionally, the protein crystallography laboratory has to remain a viable source of data for the associated discovery efforts.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image